No Data
No Data
Prestige Consumer Healthcare Insider Sold Shares Worth $959,271, According to a Recent SEC Filing
Oppenheimer Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Raises Target Price to $93
Express News | Prestige Consumer Healthcare Inc : Oppenheimer Raises Target Price to $93 From $87
Eye Drops and Lubricants Market Report 2025-2033, With Profiles of Alcon, Allergan, Bayer, Maya Biotech, Prestige Consumer Healthcare, Rohto Pharmaceutical, Sager Pharma, Similasan & More
D.A. Davidson Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Announces Target Price $104
D.A. Davidson Sticks to Their Buy Rating for Prestige Consumer Healthcare (PBH)